AVIEW LCS vs iCAC Device
AI Verdict
Choose AVIEW LCS if…
Choose AVIEW LCS if your institution requires a comprehensive AI solution for integrated cardiopulmonary assessment, including advanced lung nodule detection and analysis for lung cancer screening, alongside concurrent evaluation of COPD and coronary artery calcification from a single low-dose CT scan. This tool is ideal for streamlining radiology workflows by providing automated follow-up comparisons and detailed reporting for multiple conditions simultaneously.
View AVIEW LCS →Choose iCAC Device if…
Choose iCAC Device if your primary goal is the opportunistic identification and quantification of coronary artery calcium (CAC) from routine, non-contrast, non-gated chest CT scans already performed for other indications. This solution is best suited for leveraging existing imaging data to aid in early cardiovascular disease detection without the need for additional dedicated cardiac imaging protocols.
View iCAC Device →When choosing between AVIEW LCS and iCAC Device, physicians should consider their primary diagnostic focus and workflow integration needs. AVIEW LCS, from Coreline Soft, is a comprehensive AI solution excelling in multi-faceted cardiopulmonary assessment. It offers automated detection and analysis of lung nodules, including Lung-RADS classification and 3D segmentation, alongside emphysema quantification and coronary artery calcification (CAC) scoring. This makes it ideal for practices requiring an integrated platform for lung cancer screening and broader cardiopulmonary health assessments from a single low-dose CT scan. Its ability to compare nodules in follow-up scans and generate comprehensive reports further streamlines radiology workflows.
In contrast, Bunkerhill Health’s iCAC Device is a specialized AI algorithm focused exclusively on the detection and quantification of coronary artery calcium from routine, non-contrast, non-gated chest CT scans. Its key practical difference lies in its opportunistic identification of CAC from existing CT scans, providing adjunctive information to radiologists for early cardiovascular disease detection. Physicians whose primary need is robust, dedicated CAC scoring from a wide range of chest CT scans, and who may not require the extensive lung nodule analysis offered by AVIEW LCS, would find iCAC Device more suitable. AVIEW LCS is best for pulmonologists and oncologists, or general radiologists with a high volume of lung cancer screening, while iCAC Device is better suited for cardiologists or general radiologists looking to enhance cardiovascular risk assessment from incidental findings on chest CTs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW LCS | iCAC Device |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW LCS | iCAC Device |
|---|---|---|
| Product Name | AVIEW LCS | iCAC Device |
| Company | Coreline Soft Co. | Bunkerhill Health |
| Primary Focus | AI-powered solution for the detection and analysis of lung nodules, lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. | FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Key Analysis Capabilities | Automated lung nodule detection and analysis, Lung-RADS classification and reporting, Nodule volume quantification and 3D segmentation, Emphysema quantification (LAA index), Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass), Automated comparison of nodules in follow-up CT scans, Comprehensive, automated report generation. | Estimates presence and quantity of coronary artery calcium (CAC), Analyzes routine, non-contrast, non-gated chest CT scans, Utilizes deep-learning algorithms for analysis, Provides adjunctive information to radiologists, Outputs visual representation of estimated CAC segmentation, Delivers exact and four-category quantitative estimates of CAC burden in Agatston units. |
| Integration | Integration with PACS/RIS and third-party platforms | Integrates with PACS or DICOM router, Integrates with EHRs via the Carebricks platform |
Videos
Demos, reviews, and walkthroughs featuring AVIEW LCS and iCAC Device.